JP2025504392A5 - - Google Patents
Info
- Publication number
- JP2025504392A5 JP2025504392A5 JP2024541154A JP2024541154A JP2025504392A5 JP 2025504392 A5 JP2025504392 A5 JP 2025504392A5 JP 2024541154 A JP2024541154 A JP 2024541154A JP 2024541154 A JP2024541154 A JP 2024541154A JP 2025504392 A5 JP2025504392 A5 JP 2025504392A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- molecules
- modified
- cell
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298214P | 2022-01-10 | 2022-01-10 | |
| US63/298,214 | 2022-01-10 | ||
| US202263320691P | 2022-03-16 | 2022-03-16 | |
| US63/320,691 | 2022-03-16 | ||
| US202263322208P | 2022-03-21 | 2022-03-21 | |
| US63/322,208 | 2022-03-21 | ||
| US202263352605P | 2022-06-15 | 2022-06-15 | |
| US63/352,605 | 2022-06-15 | ||
| US202263353534P | 2022-06-17 | 2022-06-17 | |
| US63/353,534 | 2022-06-17 | ||
| PCT/US2023/060341 WO2023133568A2 (en) | 2022-01-10 | 2023-01-09 | Hypoimmune beta cells differentiated from pluripotent stem cells and related uses and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504392A JP2025504392A (ja) | 2025-02-12 |
| JP2025504392A5 true JP2025504392A5 (https=) | 2026-01-19 |
Family
ID=87074351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541154A Pending JP2025504392A (ja) | 2022-01-10 | 2023-01-09 | 多能性幹細胞から分化した低免疫性β細胞ならびに関連する使用及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250223564A1 (https=) |
| EP (1) | EP4463171A4 (https=) |
| JP (1) | JP2025504392A (https=) |
| KR (1) | KR20240142624A (https=) |
| AU (1) | AU2023204829A1 (https=) |
| CA (1) | CA3246902A1 (https=) |
| IL (1) | IL314029A (https=) |
| MX (1) | MX2024008571A (https=) |
| WO (1) | WO2023133568A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024264889A1 (en) * | 2023-05-03 | 2025-11-13 | Sana Biotechnology, Inc. | Methods of dosing and administration of engineered islet cells |
| US20250057880A1 (en) * | 2023-07-28 | 2025-02-20 | Vertex Pharmaceuticals Incorporated | Cell therapy for diabetes |
| CN116732099B (zh) * | 2023-08-07 | 2023-11-24 | 北赛泓升(北京)生物科技有限公司 | 一种干细胞多重CRISPR/Cas基因组编辑方法 |
| WO2025117331A1 (en) | 2023-12-01 | 2025-06-05 | Eli Lilly And Company | Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same |
| WO2025212859A1 (en) * | 2024-04-03 | 2025-10-09 | Solid Biosciences, Inc. | Methods and constructs for increasing solid organ transplant survival |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3344758B1 (en) * | 2015-09-01 | 2021-09-29 | Ncardia B.V. | An in vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population |
| JP2020505025A (ja) * | 2017-01-13 | 2020-02-20 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 免疫工学的な改変をした多能性細胞 |
| CA3109078A1 (en) * | 2018-07-17 | 2020-01-23 | The Regents Of The University Of California | Cells differentiated from immunoengineered pluripotent cells |
| WO2020018620A1 (en) * | 2018-07-17 | 2020-01-23 | The Regents Of The University Of California | Chimeric antigen receptor t cells derived from immunoengineered pluripotent stem cells |
| AU2021262766A1 (en) * | 2020-04-27 | 2022-11-24 | Sana Biotechnology, Inc. | Repeat dosing of hypoimmunogenic cells |
-
2023
- 2023-01-09 KR KR1020247026729A patent/KR20240142624A/ko active Pending
- 2023-01-09 CA CA3246902A patent/CA3246902A1/en active Pending
- 2023-01-09 EP EP23737829.4A patent/EP4463171A4/en active Pending
- 2023-01-09 MX MX2024008571A patent/MX2024008571A/es unknown
- 2023-01-09 IL IL314029A patent/IL314029A/en unknown
- 2023-01-09 AU AU2023204829A patent/AU2023204829A1/en active Pending
- 2023-01-09 WO PCT/US2023/060341 patent/WO2023133568A2/en not_active Ceased
- 2023-01-09 JP JP2024541154A patent/JP2025504392A/ja active Pending
- 2023-01-09 US US18/727,670 patent/US20250223564A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025504392A5 (https=) | ||
| JP2021518161A (ja) | 免疫療法の改善のための遺伝子調節組成物及び遺伝子調節方法 | |
| JP2022543112A (ja) | Ｄｕｘ４発現細胞およびそれらの使用 | |
| JP2021518162A (ja) | 免疫療法の改善のための遺伝子調節組成物及び遺伝子調節方法 | |
| JP2021518160A (ja) | 免疫療法の改善のための遺伝子調節組成物及び遺伝子調節方法 | |
| TW202302841A (zh) | 用於調變ｃａｒ－ｔ活性之方法與組成物 | |
| US20250223564A1 (en) | Hypoimmune beta cells differentiated from pluripotent stem cells and related uses and methods | |
| US12448437B2 (en) | Transplant tolerance induction with carbodiimide treated tolerizing vaccine | |
| JP2024503291A (ja) | ユニバーサルドナー細胞 | |
| KR20240137574A (ko) | 자가면역 질환 치료를 위한 키메라 항원 수용체[chimeric antigen receptor, car] t 세포 및 관련 방법 | |
| KR20240073006A (ko) | 동종이계 세포 요법을 위한 유전자 변형된 1차 세포 | |
| US20250186493A1 (en) | Artificial antigen-specific immunoregulatory t (airt) cells | |
| US20240132843A1 (en) | Methods for expanding regulatory t cells | |
| EP4090338A1 (en) | T-cell death associated gene 8 (tdag8) modulation to enhance cellular cancer therapies | |
| Maffini et al. | The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia | |
| CA3174673A1 (en) | Monoamine oxidase inhibitors as modifiers of beta cell vulnerability in type 1 diabetes | |
| US20260048086A1 (en) | Methods of dosing and administration of engineered islet cells | |
| US20240124840A1 (en) | Genetically modified cells and uses thereof for prevention of acute graft-versus-host disease | |
| WO2026059868A2 (en) | Immunosuppression resistant t cells for post-transplant disorders | |
| Darden | Regulation of Islet Cell Differentiation and Function by Calcineurin/NFATc2 Signaling and Applications for Islet Cell Transplantation | |
| CN118451181A (zh) | 工程化用于基于细胞的疗法的细胞以及相关组合物和方法 | |
| IL300524A (en) | Allogeneic reactive immune cell exclusion device and its uses for protecting cells from a donor source from allogeneic rejection |